In the BioHarmony Drug Report Database

"Preview" Icon

Pentostatin

Nipent (pentostatin) is a small molecule pharmaceutical. Pentostatin was first approved as Nipent on 1991-10-11. It is used to treat hairy cell leukemia in the USA. The pharmaceutical is active against adenosine deaminase. In addition, it is known to target adenosine deaminase.

 

Trade Name

 

Nipent
 

Common Name

 

pentostatin
 

ChEMBL ID

 

CHEMBL1580
 

Indication

 

hairy cell leukemia
 

Drug Class

 

Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)

Image (chem structure or protein)

Pentostatin structure rendering